Search Results

postdoctoral training at Boston Children’s Hospital and Harvard Medical School, he joined the lab of Dr

. 🎧 Listen to the full conversation with Dr. David Hodson

Monthly AMAs  where you can challenge Dr. Kenakin with your own enzyme or GPCR interaction puzzles.

of Staff Postdoctoral Fellow, Biochemical And Cellular Pharmacology Project Leader, Biology Explore Dr

Receptor 2 In Diabetic Retinopathy PhD Opportunity - Novel P2y Receptor Ligands For Drug Discovery Explore Dr

It's starting to look a lot like Christmas at Dr. GPCR!

Applying Allosteric Modulator Pharmacology to Treat Dyskinesia and Other Movement Disorders with Tim Dyer Addex Therapeutics "Tim Dyer is the Co-Founder and CEO of Addex Therapeutics, which is focusing on the

Developing Nations If you reside and work in a developing country, complete this form for free access to Dr

For a more detailed discussion of these concepts and additional expert perspectives from Dr.

live and work  in a developing country, please complete this form to enjoy complimentary access to Dr

Developing Nations If you reside and work in a developing country, complete this form for free access to Dr

Explore Dr. GPCR Ecosystem

Tim Dyer, CEO, Roger Mills, CMO and Robert Lütjens, Head of Discovery Biology, will provide a business

3D was used to predict subtype-selective ligands for dopamine receptors and adenosine receptors (He, Ben

Explore Dr. GPCR Ecosystem

strategic priorities, including pursuing additional collaborations across our portfolio,” said Tim Dyer

postdoctoral training, I joined one of the labs that participated in Latrophilins’ discovery, the lab of Dr

Dr. Rößler P, Mayer D, Tsai CJ, Veprintsev DB, Schertler GFX, Gossert AD.

which have an established role in chemokine gradients and oligomerization (Deshauer C et al. 2015; Dyer

.; Iyer, M. R.; Cinar, R.; Coffey, N.